Sarepta sinks 20% as surprise FDA AdComm for SRP-9001 adds risk
By Investing.com Staff Shares of Sarepta Therapeutics (NASDAQ:SRPT) fell 20% in pre-open trading Friday after the company announced a surprise FDA AdComm for SRP-9001, its...
Strong Buy
or
Sarepta News & Analysis
-
-
After-hours movers: First Republic resumes free-fall despite lifeline, FedEx surges on raised guidance
After-Hours Stock Movers: First Republic Bank (NYSE:FRC) 25% LOWER; falls despite getting a $30 billion lifeline from the nation's largest banks today. Shares rose 10% intra-day. ...
-
Sarepta Therapeutics announced AdCom to be held for SRP-9001
Sarepta Therapeutics, Inc. (SRPT) announced that at its late cycle meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA), the U.S. Food and Drug...
-
: Sarepta’s stock still up after Tuesday’s announcement that its Duchenne drug candidate won’t require a FDA AdCom meeting
Shares of Sarepta Therapeutics Inc. SRPT were up 18.7% in trading on Wednesday afternoon, a day after the company told investors that the Food and Drug Administration does not plan to...
-
Kohl's, Rivian and AMC Entertainment fall premarket; GM and Procter & Gamble rise
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, March 1st. Please refresh for updates. Kohl's (NYSE:KSS) stock fell 7.3% after the department store chain...
-
After-hours stock movers: Novavax sinks on results, B&G Foods gains
After-Hours Movers: Novavax (NASDAQ:NVAX) 25% LOWER; {{erl-16770||reported Q4 EPS of ($2.28), $1.09 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $357...
-
Sarepta Therapeutics Tops Q4 EPS by 23c
Sarepta Therapeutics (NASDAQ:SRPT) reported Q4 EPS of ($1.24), $0.23 better than the analyst estimate of ($1.47). Revenue for the quarter came in at $258.4 million versus the consensus...
-
Sarepta earnings beat by $0.23, revenue topped estimates
Investing.com - Sarepta (NASDAQ: SRPT) reported fourth quarter EPS of $-1.24, $0.23 better than the analyst estimate of $-1.47. Revenue for the quarter came in at $258.4M versus the...
-
The time for a Sarepta Therapeutics takeover is 'ripe' state analysts
By Sam Boughedda Oppenheimer analysts said in a note Friday that Sarepta Therapeutics Sarepta Therapeutics Inc (NASDAQ:SRPT) is "ripe" for a takeover. The analysts, who have an...
-
Sarepta Therapeutics Tops Q3 EPS by 54c
Sarepta Therapeutics (SRPT) reported Q3 EPS of ($0.80), $0.54 better than the analyst estimate of ($1.34). Revenue for the quarter came in at $230.27 million versus the consensus estimate of...
-
Sarepta Therapeutics Misses Q2 EPS by 7c, Offers Guidance
Sarepta Therapeutics (NASDAQ:SRPT) reported Q2 EPS of ($1.18), $0.07 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $233.5 million versus the consensus...
-
Sarepta Therapeutics Rallies on BLA Submission Intent
By Sam Boughedda Sarepta Therapeutics (NASDAQ:SRPT) announced Friday it intends to submit a Biologics License Application (BLA) seeking accelerated approval for SRP-9001. Sarepta shares...
-
Pre-Open Movers: Amazon, Apple Gain on Results; Intel Plummets on Disappointment
Pre-Open Stock Movers: Roku (NASDAQ:ROKU) 26% LOWER; {{erl-1050149||reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...
-
Pre-Open Stock Movers 06/24: Zendesk Surges on Surprise Deal; LendingTree Falls on Lower Outlook (More...)
Pre-Open Stock Movers:Zendesk, Inc. (NYSE:ZEN) 30% HIGHER; entered into a definitive agreement to be acquired by an investor group led by leading global investment firms Permira and Hellman...
-
FedEx, Netflix, Microsoft Rise Premarket; Smith & Wesson Falls
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, June 24. Please refresh for updates. FedEx (NYSE:FDX) stock rose 2.6% after the delivery giant reported higher...
-
Sarepta Therapeutics Shares Down 3% on FDA's Clinical Hold on SRP-5051
By Davit Kirakosyan Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares were trading more than 3% lower after-hours following the company’s announcement, according to which the U.S. Food and...
-
Sarepta Therapeutics Posts Smaller Q1 Loss
Sarepta Therapeutics (NASDAQ:SRPT) reported Q1 EPS of ($0.56), $0.71 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $188.8 million versus the consensus...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.05%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Consumer Goods, Utilities and Technology sectors propelled shares higher while losses in the Telecoms, Basic...
-
Moderna’s Vaccine Rally Takes $427 Million Bite Out of Shorts
(Bloomberg) -- Betting against Moderna (NASDAQ:MRNA) Inc. may be a risky proposition right now after a first look at its Covid-19 vaccine in humans drove the shares to fresh highs. The...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.01%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Utilities, Technology and Consumer Goods sectors propelled shares higher. At the close in NYSE, the Dow...
-
Deals of the day-Mergers and acquisitions
Feb 27 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:** Amazon.com Inc AMZN.O , Comcast Corp CMCSA.O and Electronic Arts Inc...
-
Top 5 Things To Know In The Market On Wednesday
Investing.com - Here are the top five things you need to know in financial markets on Wednesday, August 8: 1. Chinese Exports Accelerate Even As Trump Escalates Trade War China's exports...
-
Economic Calendar - Top 5 Things To Watch This Week
Investing.com - Escalating trade rhetoric will keep investors on their toes in the week ahead, as they watch further developments in the ongoing trade war between the United States and...
-
US STOCKS-Wall St opens higher as energy, financial stocks rise
* Hurricane Irma possibly en route to Florida * Federal Reserve issues Beige Book at 02:00 p.m. E.T. * U.S. trade deficit rises less than expected * Indexes up: Dow 0.30 pct, S&P 0.24...
-
US STOCKS-Wall St set to open higher even as N.Korea tensions weigh
* Hurricane Irma possibly en route to Florida * Federal Reserve issues Beige Book at 02:00 p.m. E.T. * U.S. trade deficit rises less than expected * Futures up: Dow 40 pts, S&P 3.75...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13%
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Telecoms, Utilities and Healthcare sectors propelled shares higher while losses in the Basic Materials, Oil...
-
US STOCKS-Tech stocks, Deutsche Bank lift Wall Street
* U.S. shares of Deutsche Bank up 2.2 pct* Darden up as 1st-qtr sales rise* Indexes up: Dow 0.21 pct, S&P 0.13 pct, Nasdaq 0.34 pct (Updates to open)By Yashaswini SwamynathanOct 4...
-
US STOCKS-Wall St set for subdued start; Deutsche Bank in focus
* U.S. shares of Deutsche Bank up 2 pct premarket* Dollar index surges to near two-week high* Darden up as 1st-qtr sales rise* Futures up: Dow 3 pts, S&P 0.75 pts, Nasdaq 5.75 pts...
-
US STOCKS-Futures little changed ahead of Yellen's testimony
* Futures: Dow down 0.25 pts, S&P up 1.75 pts, Nasdaq up 11 ptsBy Yashaswini SwamynathanSept 28 (Reuters) - U.S. stock index futures were little changed on Wednesday as investors awaited...
-
US STOCKS-Wall St set to open higher as investors await Fed meet
* Fed Chair Yellen to speak at 2:00 p.m. ET Wednesday * DTS soars on $850 mln acquisition agreement with Tessera * Tobira Therapeutics rises six-fold on Allergan (NYSE:AGN_pa) deal *...
-
US STOCKS-Futures up as investors await Fed meeting
* Futures up: Dow 56 pts, S&P 7.25 pts, Nasdaq 16.75 pts By Yashaswini Swamynathan Sept 20 (Reuters) - U.S. stock index futures were higher as investors saw little room for the Federal...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.02%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Telecoms, Healthcare and Consumer Services sectors propelled shares lower. At the close in NYSE, the Dow...
-
US STOCKS-S&P, Dow lifted by financials; Fed in focus
* Fed's monetary policy meet starts Tuesday* Sarepta soars after FDA approves muscle drug* Apple drags down Nasdaq* Dow up 0.21 pct, S&P up 0.19 pct, Nasdaq down 0.02 pct (Updates...
-
US STOCKS-Wall St rises on gains in financial, energy stocks
* Fed's monetary policy meet starts Tuesday* Oil prices rise more than 2 pct* Sarepta soars after FDA approve muscle drug* Indexes up: Dow 0.50 pct, S&P 0.43 pct, Nasdaq 0.26 pct...
-
US STOCKS-Wall Street flat as Apple-led tech gains offset energy losses
* Oil prices extend losses, down 1.15 pct* Apple rises for 3rd day in a row; boosts all indexes* Sarepta jumps as key drug critic leaves FDA* Indexes up: Dow 0.07 pct, S&P 0.1 pct,...
-
US STOCKS-Wall Street set to open higher
* Oil prices reverse course to trade lower * Sarepta jumps as key drug critic leaves FDA * Futures up: Dow 26 pts, S&P 3.5 pts, Nasdaq 14.5 pts (Adds details, comments, updates...
-
US STOCKS-Futures inch higher with oil prices
* Futures up: Dow 16 pts, S&P 3 pts, Nasdaq 10.25 pts By Yashaswini Swamynathan Sept 14 (Reuters) - U.S. stock index futures treaded water on Wednesday, after a broad selloff a day...
-
US STOCKS-Wall St set to open little changed after BoE cuts rates
* BoE cuts lending rate to record low * Weekly jobless claims rise to 269,000 vs est. 265,000 * Monthly U.S. jobs data expected on Friday * Viacom rises on surprise revenue growth *...
-
US STOCKS-Futures slightly higher after BoE cuts rates
* Futures: Dow up 29 pts, S&P up 3 pts, Nasdaq down 0.5 pts By Yashaswini Swamynathan Aug 4 (Reuters) - U.S. stock index futures were slightly higher after the Bank of England cut...
-
US STOCKS-S&P just shy of record on oil rally, biotechs curb Nasdaq
* S&P 500 16 points shy of May 2015 record high * Oil prices hit 2016 highs; Exxon (NYSE:XOM) hits 52-week high * Biogen, Alexion drop after drug trial failures * Indexes up: Dow...
-
US STOCKS-Futures up after Yellen eases worries over economic health
* Futures up: Dow 49 pts, S&P 5 pts, Nasdaq 14.5 pts By Yashaswini Swamynathan June 7 (Reuters) - U.S. stock index futures were higher on Tuesday, a day after Federal Reserve Chair...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.27%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Healthcare, Telecoms and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.82%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Oil & Gas, Basic Materials and Technology sectors propelled shares higher. At the close in NYSE, the Dow...
-
US STOCKS-Wall St rallies as higher oil boosts energy stocks
* Oil prices edge toward $50/barrel * Alibaba (NYSE:BABA) falls after SEC launches investigation * Computer Sciences jumps after Hewlett Packard Enterprise deal * Indexes rise: Dow 0.53...
-
US STOCKS-Wall St looks set to extend rally as oil rises
* Oil prices edge toward $50/barrel * Tiffany falls after reporting steepest sales drop in 7 yrs * Computer Sciences jumps after Hewlett Packard Enterprise deal * Futures rise: Dow 68...
-
US STOCKS-Futures track rise in global equities, oil
* Futures rise: Dow 60 pts, S&P 7.25 pts, Nasdaq 18.50 pts By Tanya Agrawal May 25 (Reuters) - U.S. stock index futures were higher on Wednesday, mirroring global equities, as oil...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.63%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Telecoms, Utilities and Consumer Goods sectors propelled shares lower. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
